Vialwirebiotech, curated
November 21, 2026, 3:41 PM
July 30, 2026
- 4:12 PM · BioPharma Dive4:12 PMAlnylam plunges as earnings deliver ‘one-two punch’ — BioPharma Dive
- 1:10 PM · MIT Technology Review1:10 PMMontana’s plan to become an experimental medical hub just pushed forward — MIT Technology Review
- 11:52 AM · BioPharma Dive11:52 AMJ&J nabs option to buy ‘in vivo’ CAR-T maker Sail for nearly $2.6B — BioPharma Dive
- 11:33 AM · Pharmaceutical Technology11:33 AMPfizer seeks label expansion for Litfulo after double Phase III NSV win — Pharmaceutical Technology
- 10:07 AM · Pharmaceutical Technology10:07 AMAustralia approves first-in-class Niktimvo for later-line cGVHD — Pharmaceutical Technology
- 9:12 AM · PharmaVoice9:12 AMHow Telix landed a $2.1 billion radiopharma deal with Regeneron — PharmaVoice
- 9:00 AM · BioWorld9:00 AMSeed funding at Adjuvia to treat mitochondrial dysfunction — BioWorld
- 9:00 AM · BioWorld9:00 AMQnovia licenses antimicrobial peptide from University of Virginia — BioWorld
- 9:00 AM · BioWorld9:00 AMIksuda’s IKS-04 gains IND clearance for gastrointestinal cancers — BioWorld
- 9:00 AM · BioWorld9:00 AMAbcellera and Vertex partner on TCEs for autoimmune diseases — BioWorld
- 9:00 AM · BioWorld9:00 AMElix and University of Vienna collaborate on AI drug discovery — BioWorld
- 8:00 AM · Pharmaceutical Executive8:00 AM<![CDATA[DSCSA Compliance Guide: What to do now that enforcement as begun]]> — Pharmaceutical Executive
- 7:00 AM · Drug Discovery World7:00 AMQureight closes $20 million Series B financing — Drug Discovery World
- 5:41 AM · Pharmaceutical Technology5:41 AMAmgen’s Repatha receives positive CHMP opinion for broader cardiovascular use — Pharmaceutical Technology
- 5:00 AM · Pharmaceutical Technology5:00 AMSynlogic and Caldera sign merger agreement — Pharmaceutical Technology
- 4:57 AM · Drug Discovery World4:57 AMPerspective receives European orphan medicinal product designation — Drug Discovery World
- 3:20 AM · Bloomberg — Technology3:20 AMEuropean Stocks Advance on Busy Earnings Day; Sanofi Slumps — Bloomberg — Technology
July 29, 2026
- 5:00 PM · STAT News
- 12:00 PM · BioWorld12:00 PMAtea’s hep C pill looks solid in phase III head-to-head HCV study — BioWorld
- 10:49 AM · Pharmaceutical Technology10:49 AMAdCom expected for uniQure’s Huntington’s gene therapy, chief medical officer says — Pharmaceutical Technology
- 10:34 AM · Pharmaceutical Technology10:34 AMDimerix acquisition of DMX-652 bolsters kidney disease development — Pharmaceutical Technology
- 10:17 AM · Pharmaceutical Executive10:17 AM<![CDATA[FDA Approves Viatris’ Gwyn Lo Contraceptive Patch ]]> — Pharmaceutical Executive
- 9:00 AM · BioWorld9:00 AMCore Biomedicine licenses Eisai oncology programs, raises funds — BioWorld
- 9:00 AM · BioWorld9:00 AMTorrey Pines Medicine secures funding to advance metabolic programs — BioWorld
- 9:00 AM · BioWorld9:00 AMMJFF grant supports Shape’s SHP-201 through IND-enabling studies — BioWorld
- 8:00 AM · Drug Discovery World8:00 AMPhase I study for prevention of chemotherapy-induced peripheral neuropathy — Drug Discovery World
- 6:30 AM · Drug Discovery World6:30 AMAsthma drug Trixeo recommended for approval in the EU — Drug Discovery World
- 5:21 AM · Drug Discovery World5:21 AMGSK plans new flagship R&D centre and £400m investment in UK — Drug Discovery World
- 3:50 AM · Pharmaceutical Technology3:50 AMEisai and CORE Biomedicine agree on global licence for oncology pipeline — Pharmaceutical Technology
July 28, 2026
- 5:21 PM · SCMP — Tech5:21 PMNvidia CEO Jensen Huang meets US officials as scrutiny grows over China chip access — SCMP — Tech